Immune response variables and viral mutations impact on COVID-19 reinfection and relapse-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune response variables and viral mutations impact on COVID-19 reinfection and relapse

Published:2021-11 Issue: Volume:100 Page:108108
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Sanaie Sarvin^ORCID,Golipour Elham,Shamekh Ali^ORCID,Sadaie Mohammad Reza,Mahmoodpoor Ata^ORCID,Yousefi Mehdi^ORCID

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference136 articles.

1. who.int [cited 2020]. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update---24-november-2020.

2. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China;Wang;JAMA,2020

3. Clinical Characteristics of Coronavirus Disease 2019 in China;Guan;N. Engl. J. Med.,2020

4. Covid-19: risk factors for severe disease and death;Jordan;Br. Med. J. Publishing Group,2020

5. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China;Dong;Pediatrics,2020

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting the spread of SARS-CoV-2 variants: An artificial intelligence enabled early detection;PNAS Nexus;2023-12-21

2. Slowly but surely: Exposure of communities and infrastructure to subsidence on the US east coast;PNAS Nexus;2023-12-21

3. Risk and severity of SARS-CoV-2 reinfection among patients with multiple sclerosis vs. the general population: a population-based study;BMC Neurology;2022-10-08

4. Promising use of immune cell‐derived exosomes in the treatment of SARS‐CoV‐2 infections;Clinical and Translational Medicine;2022-08

5. Clinical manifestations, treatment options, and comorbidities in COVID‐19 relapse patients: A systematic review;Journal of Clinical Laboratory Analysis;2022-04-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3